Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com
Third quarter GAAP revenue of $801 million, and non-GAAP revenue
of $805 million
Third quarter GAAP earnings per share of $0.22, and non-GAAP
earnings per share of $0.73
Free cash flow of $164 million in the third quarter
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 27, 2009--
Life Technologies Corporation (NASDAQ:LIFE) today announced results for
its third quarter ended September 30, 2009. Non-GAAP revenue for the
...
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 22, 2009--
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE),
today announced the global commercial availability of a new capillary
electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer
builds on Applied Biosystems’ industry-leading CE sequencing systems,
with state-of-the-art advancements, setting significant new standards
for throughput, data quality and ease of ...
SOLiD™ 3 Plus Enables Higher Throughput, Decreased Cost, and Faster
Data Analysis on Life Science Industry’s Most Accurate Sequencing
Platform
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 21, 2009--
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE)
today announced the commercial availability of the SOLiD™ 3 Plus System,
an enhanced next-generation genomic analysis platform designed to allow
research...
Sales Leader to Bring Years of Experience to Key Role within
Commercial Operations
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 14, 2009--
Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative
life science solutions, today announced that it has named Jay Therrien
to the position of Vice President, Global Sales for Next Generation
Sequencing. In this role, Therrien will be responsible for all sales
activities related to Li...
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
